26.04.2024 14:07:40 - dpa-AFX: *GILEAD SCIENCES: FDA APPROVES BIKTARVY(R) LABEL UPDATE WITH DATA FOR PREGNANT ADULTS WITH HIV

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Gilead Sciences 885823 NASDAQ 71,455 23.07.24 19:47:33 -0,955 -1,32% 71,440 71,460 71,950 72,410

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH